-
The federal “test-to-treat” program was designed to be a one-stop shop for people to get tested and receive treatment. But as cases rise again, many communities have no participating locations, and website bugs make it difficult to book an appointment at the biggest participant.
-
The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage and can be used in doctor’s offices, hospitals and mobile testing sites.
-
Although at-home antigen testing remains a useful tool, experts warn it is often used inappropriately and can provide false confidence for people concerned about safety.
-
Germans pay less than $1 per test. Brits get them free. Why do Americans pay so much more? Because companies can still demand it.
-
The Lucira COVID-19 All-In-One Test Kit is expected to provide results in 30 minutes or less. Its approval could help alleviate the strain on the nation's precarious coronavirus testing system.
-
In a letter to the HHS secretary and governors, Sen. Rick Scott said Congress has not received information from states on the antigen tests.
-
Florida has received its first shipment of 400,000 rapid “antigen” test kits from the federal government, and Gov. Ron DeSantis announced at a news…
-
More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus, which has…
-
Less than two months after state-run COVID testing sites were overwhelmed with demand amid a surge in new infections, Florida officials are turning to a…
-
The state is severing ties with Quest Diagnostics after the company did not timely report to the Florida Department of Health nearly 75,000 COVID-19 test…